MVA LS2(University of Oxford)(MVA LS2(University of Oxford))

概要

基本信息

药物类型

预防性疫苗

别名-

靶点-

作用机制

免疫刺激剂

治疗领域

感染

在研适应症-

非在研适应症

疟疾

原研机构

University of Oxford

在研机构-

非在研机构

University of Oxford

最高研发阶段无进展临床1/2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

2

项与 MVA LS2(University of Oxford) 相关的临床试验

NCT03203421

/ Completed临床1/2期IIT

A Phase I/II Study to Assess the Safety, Immunogenicity and Protective Efficacy of Novel Malaria Vaccine Candidates ChAdOx1 LS2 and MVA LS2 in Healthy UK Adults

The purpose of this study is to assess the safety, immunogenicity and efficacy of the candidate malaria vaccines ChAdOx1 LS2 and MVA LS2.
Healthy adult volunteers will be recruited and vaccinated in Oxford.

开始日期2017-07-03

申办/合作机构

University of Oxford

EUCTR2017-001049-28-GB

/ Not yet recruiting临床1/2期IIT

A Phase I/II Study to assess the safety, immunogenicity and protective efficacy of novel malaria vaccine candidates ChAdOx1 LS2 and MVA LS2 in healthy UK adults - A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2 (VAC067)

开始日期2017-05-26

申办/合作机构-

100 项与 MVA LS2(University of Oxford) 相关的临床结果

登录后查看更多信息

100 项与 MVA LS2(University of Oxford) 相关的转化医学

登录后查看更多信息

100 项与 MVA LS2(University of Oxford) 相关的专利（医药）

登录后查看更多信息

100 项与 MVA LS2(University of Oxford) 相关的药物交易

登录后查看更多信息